Definium’s LSD-based therapy elicits ‘profound’ efficacy in Phase 3 depression trial

Results for Definium Therapeutics psychedelic candidate for major depressive disorder “exceeded expectations,” according to Stifel, while Jefferies called the efficacy data “profound.”